tiprankstipranks
Apollomics (APLM)
NASDAQ:APLM
US Market
Holding APLM?
Track your performance easily

Apollomics (APLM) Financial Statements

276 Followers

Apollomics Financial Overview

Apollomics's market cap is currently ―. The company's EPS TTM is $-0.62; its P/E ratio is -15.72; Apollomics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue---$ 0.00$ 0.00
Gross Profit-----
EBIT---$ -383.85K$ -389.37K
EBITDA---$ -383.85K$ -389.37K
Net Income Common Stockholders---$ -236.99K$ -355.96K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 32.06M$ 32.67M-$ 279.27K$ 301.95K
Total Assets$ 55.39M$ 76.47M-$ 105.56M$ 105.48M
Total Debt$ 5.66M$ 991.00K$ 0.00$ 0.00$ 0.00
Net Debt$ -26.39M$ -31.68M$ 0.00$ -279.27K$ -301.95K
Total Liabilities$ 14.15M$ 538.86M-$ 4.00M$ 3.68M
Stockholders Equity$ 41.23M$ -462.39M-$ 101.56M$ 101.80M
Cash Flow-
Free Cash Flow---$ -71.66K$ -297.01K
Operating Cash Flow---$ -71.66K$ -297.01K
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Apollomics Earnings and Revenue History

Apollomics Debt to Assets

Apollomics Cash Flow

Apollomics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis